Extracellular Vesicle-Derived mir-148a-3p Promotes Plasmablast Differentiation in Bullous Pemphigoid via BACH2 Repression and mTOR Activation
Listen to this summary
This study aims to elucidate the molecular mechanisms behind plasmablast differentiation in bullous pemphigoid (BP), an autoimmune blistering disease. The authors found that extracellular vesicle-derived miR-148a-3p enhances plasmablast differentiation by repressing BACH2 and activating the mTOR signaling pathway, suggesting a novel regulatory mechanism in BP pathogenesis and highlighting miR-148a-3p as a potential diagnostic and therapeutic target.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from The Journal of investigative dermatology
View all →More in Dermatology
View all →Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 22, 2026 · Lancet (London, England)
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
Sep 22, 2026 · Lancet (London, England)
Understanding peripheral arterial disease in the current era
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
